Latest Prescription Drugs news
FDA May Limit Use of Two COVID-19 Antibody Treatments
posted January 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
Opioid Overdose Antidote Urged for Schools After Student’s Fentanyl Death
posted January 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
Biosimilars Could Cut Spending for Biologic Therapy in the U.S.
posted January 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Semaglutide Superior to Liraglutide for Weight Loss
posted January 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
2018 to 2025 Saw Sharp Rise in Postpartum GLP-1 Receptor Agonist Use 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Monthly Specialist Briefings
Stay Connected
